Fosun Pharma opens online reservation platform for BioNTech vaccination as Covid border controls are set to end

The shot will be available over the next few weeks as the two countries are still working out the ‘final details’ of the agreement, Berlin’s envoy to China says

World’s most widely used mRNA vaccine languishes unapproved in China as Fosun Pharma and BioNTech see window of opportunity closing

CanSino’s net income fell 99% in the first half, while Fosun reported a decline of more than one-third

In a race to develop advanced Covid inoculations, Chinese vaccine-makers lack technical expertise, ingredients, production equipment and delivery system

German developer’s mRNA-based Comirnaty shot is one of the most widely used worldwide, with data already showing its high efficacy

There’s a long way to go in rolling out the advanced shots for China as Western companies control patents and Chinese companies face technological barriers

Among the newly vaccinated, 61% opted for a shot from Sinovac despite reports showing that it is less potent against omicron and other strains

China’s central bank cuts rates on relending facilities for small businesses and rural sectors. IQiyi fires hundreds of workers as losses balloon

Approval of shot targeting new Covid variant may take three to four months, but the public doesn’t ‘need to panic,’ Chinese drugmaker says

China doubles down on Covid-zero strategy, vaccinating children as young at 3, rolling out mass booster shots and developing more effective vaccines

Loans from Asian Infrastructure Investment Bank and International Finance Corp. will fund expanded mRNA vaccine output and distribution

Company still waiting for approval to manufacture and sell German-developed Covid vaccine to Chinese mainland

Drug regulators complete an expert review of a Covid-19 mRNA jab developed by Fosun Pharma and the German pharmaceutical company

Shanghai-based drug giant will sell 10 million doses of BioNTech’s cutting-edge Covid-19 vaccine to groups connected to local billionaire Terry Gou, chipmaker TSMC

Advanced mRNA vaccine for Covid-19 nears completion of regulatory reviews as drugmakers start preparing Shanghai factory

92-year-old billionaire gets second dose of the BioNTech shot, his foundation announces

City’s government has ordered 7.5 million doses of the shot, but only 1.24 million have been administered

Fosun and BioNTech are to set up a joint venture to produce a Covid-19 vaccine. Three Chinese telecom companies are to be delisted from the NYSE

Pair will build Shanghai factory with capacity to make 1 billion doses of German company’s mRNA-based inoculations each year